Summary: A method is described for the semi-automated measurement of inulin concentrations in serum and urine in the presence of glucose. The concentration of glucose is measured simultaneously and is used to correct for almost all "inulin-like" interferences. The inulin Standard curve is linear over a wide ränge (5-2500 mg/1). Betweenrun precision is < 6% and recovery from spiked sera is 98%. This method offers the possibility of measuring glomerular filtration rate in patients with varying glucose concentrations (e. g. diabetics).
Introduction
Inulin is an uncharged fhictose polymer with an average relative molecular mäss of 5200. It does not bind to plasma proteins and distributes freely in the extracellular fluid. Inulin is eliminated by filtration through the glomerulus and is not reabsorbed, secreted or metabolised at the tubulus. Thus, renal inulin clearänce using a constänt infusion is the "gold Standard" for measuring glomerular filtration rate, any extrarenal elimination being stable with constant plasma inulin concentrations (1) . Most methods for the meäsufement of inulin in plasma or urine are based on the estimatioii of fhictose. Inulin is hydrolysed to fhictose in a protein free filtrate, follöwed by a coloripietric assay of fhictose using ß-indolylacetic acid (2) , resorcinol (3) or anthrone (4).
Carbohydrates, especially glucose, imteffere with these methods by increasing the absorbance, resülting in an overestimation of the inulin concentration. Unstable plasma glucose eoncentrations, which may occur in diabetics, result in additional errors, which may be enhanced if glycosuria develops when plasma glucose concentrations are above the renal threshold. Obviously this excludes the use of the inulin clearanee test for these patients. To overcome this problem glucose has been eliminated enzymatically prior to the test (5). Alternative methods have been developed using speciific enzymatic assays (6, 7), or refined techniques such äs HPLC (8), requiring special equipment.
We developed a semi-automated method for inulin determination in serum and urine samples, in which the glucose concentration in measured simultaneously. In this way we are able to correct for almost all the "inulinlike" interference.
Materials and Methods
Chemicals and Solutions 1. Standard inulin Solutions: Inulin from Merck (Darmstadt, Germany) was dried in a desiccator for at least 48 hours and dissolved in (hol) water to make a 10000 mg/1 Standard solution. From this a 200, 400, 600, 800 and 1000 mg/1 working Standard was prepared.
2. Glucose Standard Solutions: Glucose was purchased from Merck, the following Standard Solutions were made: 2.5, 5, 10 and 20 mmol/1.
3. Anthrone solution. Two grams of anthrone (Sigma) was dissolved in 700 g/kg sulphuric acid. The solution was stored in the dark and was stable for at least l week. 4 . Reagents of p. a. quality were obtained from Merck, unless otherwise specified. General description of the method Urine samples are diluted four times with water. Then serum or diluted urine is deproteinized and placed in a sample cüp.
After aspiration the inulin in the sample is hydrolysed to fructose in 700 g/kg sulphuric acid for 5 min in a heating bath. Fructose reacts with anthrone to produce a blue-green compound. Its concentration is determined by measuring the absorbance at 630 nrn. Glucose is determined in a parallel sample stream. The inulin-like absorbance of the glucose Standards measured in the inulin-assayunit is used to construct a glucose correction curve.
V* Flow procedure in the autoanalyser
The following units of the Autoanalyser are used: sampler, pumps, single and double mixing coils, heating baths, colorimeters and recorders.
Because inulin cannot be dialysed in this System, a sample (0.2 ml) is deproteinized manually by the addition of 1.8 ml trichloroacetic acid (50 g/l). After mixing and centrifugation (5min, 2000 g) a portion of the supernatant is placed in a sample cup. Inulin Standards are processed the same way äs serum samples.
Each sample is diluted 10-fold with water in the predilution cartridge ( fig. 1 ), then mixed in a double mixing coil, after which the sample stream is split: one part enters the glucose analysing unit ("blank cartridge") using the Standard method frorn Technicon for measurement of glucose with hexokinase. The other part enters the inulin analysing unit ("assay cartridge").
In the assay cartridge the diluted sample is mixed with 700 g/kg sulphuric acid in a double mixing coil. Then anthrone solution is added. After complete mixing in a single mixing coil, the solution enters the first heating bath at 90 °C, and after 2.85 min the second bath at 50 °C for 2.15 min. By using two baths to lengthen the mcubation time, we were able to increase the ränge of the calibration line. The colorimetric reading is performed in a 1.5 mm flow cell, with a 630 mm filter. The acid and anthrone Solutions are aspirated frorn the Containers by acidflex tubing.
Sampling time is 90 s. Between two samples, the sampling probe is rinsed and water is aspirated for 90 s. We constructed the inulin °a nd glucose Standard curve with five Standard Solutions of inulin and five Standard Solutions of glucose respectively.
Patient material
Four patients with chronic renal^failure and 2 patients with noninsulin-dependent diabetes mellitus received an inulin dose of 75 mg/kg lean body mass (9) by intravenous infusion during 5 min. The characteristics of the patients are shown in table l. A "preinulin" blank sample frorn every patient was analysed for inulin, corrected for glucose interfererice, and the remaining "inulin-like" (which is of non-glucose and non-inulin origin) concentration was subtracted frorn the inulin concentration in the subsequent samples.
In both diabetic patients the interference of an exogeneous dose of glucose on the inulin concentrations was studied by giving a 25 g glucose solution intravenously at t = 180 min. Serum inulin concentrations corrected for glucose were compared with senim inulin concentrations not corrected for glucose.
Stastistical analysis
Orthogonal regression analysis was performed according to Dem- 
Results

Methodology
Within-run precision is better than 0.5% in the low and the high ränge of the calibration curve. Between-run precision, measured each day at two levels for 20 days, is 5.8% at 165 mg/1 and 2.7% at 400 mg/1. The lowest measurable concentration is 5 mg/1, but sensitivity can be easily increased 10 times by omitting prior dilution or by increasing the sensitivity of the colorimeter.
Recovery experiments performed in eight different sera spiked with inulin show a recovery of 98 ± 1%. Only minor sample carryover could be detected: inulin concentration increases by 6 mg/1 (SD 2 mg/1, n = 10) in the sample pipetted directly after a 1000 mg/1 sample. The inulin calibration curve is linear over the ränge from 0 to 2500 mg/1 äs checked with 13 Standards, the coefficient of correlation being r = 0.997.
Glucose interference was investigated, using 36 inulinfree patient serum samples, with different glucose concentrations. The apparent inulin levels in these sera show a linear relationship, äs indicated in figure 2 . Also endogenous fructose in the patient samples will contribute to the apparent inulin concentration. Using fructose Standards in water, the foljowing relation was calculated: The serum concentration profile of inulin, with and without correlation for glucose in two patients with noninsulin-dependent diabetes mellitus is shown in figure  3 . The corrected inulin line shows a decline along the (table 1) . Glucose (25 g) was infused from t = 180 to 200 min, The lower profile is from patient E, the other is patient F.
extrapolated curve. The uncorrected serum inulin levels, however, show an increase at the terminal elimination phase due to the rise in serum glucose.
Discussion and Conclusion
Methodology
The semi-automated method for determining inulin in serum and urine proved to be reliable if corrected for interfering endogenous glucose. The intra-and inter-assay reproducibility is excellent. The assay ällows the sequential determination of the broad ränge of serum and urine inulin concentrations that is encountered when inulin decay curves are used in the determination of glomerular filtration rate (11) . No individual dilution Steps are required. The necessary deproteinization of serum must be performed manually, but this can be done during spare time, since the samples are stable for at least a week.
From the 'data in figure 2 , it can be calculated that without correction 10 mmol/1 glucose will increase the inulin concentration by 59 mg/1. The intercept of 21 mg/1 ( fig.  2) is not caused by the non-serum matrix of the glucose Standards. Considering the formula describing the relation between the apparent inulin and the fructose concentration, the intercept can be fiilly explained by the endogenous fructose concentration in the serum: the 21 mg/1 apparent inulin results from the reaction of anthrone with 0.12 mmol/1 fructose (fructose concentrations in serum ränge from 0.05 to 3.3 mmol/1 (12)). The method shows good correlation with the Boehringer Mannheim assay. The latter corrects not only for glucose but also for fructose, and this may be why our method gives somewhat higher results for patient samples. The enzymatic method described by Kuehnle et al. has the advantage not using aggressive chemicals, but this method shows also interferenee by endogenous glucose and fructose (not mentioned by the authors). When the enzyme, inulinase, becomes commercially available, the enzymatic method will be very»promising.
Patient studies
The ratio of creatinine to inulin clearance is greater than one in all patients (tab. 1). This is caused by tubular excretion of creatinine in addition to glomerular filtration (1). In calculating true glomerular filtration rate, correction for endogenous glucose is required beeause the apparent inulin concentration due to glucose inteiference may contribute up to 50% of the inulin concentration, especially when levels are low in the terminal elimination phase ( fig. 3 ). M diabetics this may cause erroneously high or low inulin concentrations due to Variation in blood glucose concentratioiis. With the glucose correction, the accuracy of the method in these diäbetic patients improves, especially in the lower inulin ränge. This is in agreement with others (5), who compafed a colorimetric assay with a/ specific enzymatic assay and foünd perfect agreement for low inulin concentrations, only after prior removäl of glucose. The resulting clinically important advantage is that by cörrecting for glucose in each individual sample, the method is suitable for use with diabetics.
In conclusion, this method of measuring inulin coneentrations in serum and urine is easy to perform, its accuracy and reproducibility are better than previously reported (2-4), and it can be used for investigations of patients with varying glucose concentrations, like diab etics.
